logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Niels W.C.J. van de Donk

vrije universiteit amsterdam
H指数:78
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ataxia and Balance Disorders Associated with GPRC5D-Directed Therapies in Relapsed/Refractory Multiple Myeloma: A Case Series with Practical Recommendations for Management

共济失调和平衡障碍与GPRC5D靶向疗法在复发/难治性多发性骨髓瘤中的关联：一份病例系列及管理实用建议

Clinical Lymphoma Myeloma and Leukemia
IF2.7
2026-10-270
PRE
Ja Min Byun; Vania Hungria; Niels W.C.J. van de Donk; Emma Searle; Susan Bal; Jing Christine Ye; María-Victoria Mateos; Paula Rodriguez-Otero; Sham Mailankody; Weijun Fu; Ryan Yann Shern Keh; Bianca D. Santomasso; Jaszianne Tolbert; William Terry; Fatema Malbari; Stacy Sowers; Yadgiri Rao Danda; Murali Janakiram
Multiple myeloma in the Netherlands: 35-year trends in incidence and survival

荷兰多发性骨髓瘤：35年发病率和生存趋势

Leukemia
IF13.4
2026-10-220
OAAI
Koen M. Klomberg; Wilfried W. H. Roeloffzen; Marcel Nijland; Mark-David Levin; Inger S. Nijhof; Rimke Oostvogels; Elizabeth de Kort; Ruth Wester; Catharina H. M. J. van Elssen; Esther G. M. de Waal; Paul A. F. Geerts; Yavuz M. Bilgin; Djamila E. Issa; Marjolein van de Klift; Gerwin A. Huls; Laurens E. Franssen; Cleo R. van Rooijen; Monique C. Minnema; Annemiek Broijl; Paula F. Ypma; Niels W. C. J. van de Donk; Sonja Zweegman; Mirian Brink; Wouter J. Plattel
Dual targeting of BCMA and GPRC5D with the trispecific antibody ramantamig addresses antigenic heterogeneity in myeloma

双靶向BCMA和GPRC5D的trispecific antibody ramantamig解决了骨髓瘤中的抗原异质性

HemaSphere
IF14.6
2026-10-080
OAAI
Chloe O'Neill; Marloes E. C. Broekmans; Charlotte L. B. M. Korst; Maria Krevvata; Giada Dal Collo; Richard W. Groen; Bing Li; Serena R. Baglio; Ulrike Philippar; Kodandaram Pillarisetti; Sonja Zweegman; Deeksha Vishwamitra; Tuna Mutis; Niels W. C. J. van de Donk
Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study

新诊断多发性骨髓瘤患者SLIM标准下的临床结局：CASSIOPEIA研究中的亚组分析

Leukemia
IF13.4
2026-08-130
PRE
Cyrille Touzeau; Aurore Perrot; Cyrille Hulin; Mammoun Dib; Gedeon Agbetsivi; Laure Vincent; Thierry Facon; Xavier Leleu; Niels W.C.J. van de Donk; Annemiek Broijl; Sonja Zweegman; Michel Delforge; Jill Corre; Pieter Sonneveld; Ariane Boumendil; Philippe Moreau
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients

EMN12/HOVON-129研究移植适宜队列中初发浆细胞白血病患者长期随访

Blood Cancer Journal
IF11.6
2026-06-240
OAAI
Niels W. C. J. van de Donk; Fredrik Schjesvold; Bronno van der Holt; Monique C. Minnema; Ka Lung Wu; Annemiek Broijl; Wilfried W. H. Roeloffzen; Alain Gadisseur; Giuseppe Pietrantuono; Ludek Pour; Vincent H. J. van der Velden; Thomas Lund; Massimo Offidani; Sara Bringhen; Luisa Giaccone; Wida Razawy; Paola Tacchetti; Katia Mancuso; Trine Silkjaer; Jo Caers; Sonja Zweegman; Roman Hájek; Reuben Benjamin; Annette Juul Vangsted; Mario Boccadoro; Francesca Gay; Pieter Sonneveld; Pellegrino Musto
Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma

单核细胞介导的代谢重编程通过CD31-CD38相互作用促进多发性骨髓瘤的生长和药物抗性

HemaSphere
IF14.6
2026-04-160
OAAI
Ramin Raoof; Giada Dal Collo; Helga Simon-Molas; Panagiota Tzortzi; Konxhe Kulaj; Elif N. Demirez; Crescenzo Massaro; Renée Poels; Charlotte L. B. M. Korst; Chloe A. O'Neill; Wassilis S. C. Bruins; Marloes E. C. Broekmans; Payam Behradkia; Maria Krevvata; Sonja Zweegman; Arnon P. Kater; Serena R. Baglio; Tuna Mutis; Niels W. C. J. van de Donk
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial

Isatuximab、carfilzomib、lenalidomide和dexamethasone在新诊断多发性骨髓瘤中的疗效：一项随机III期临床试验

Nature Medicine
IF50
2026-04-060
OAAI
Francesca Gay; Wilfried Roeloffzen; Meletios A. Dimopoulos; Laura Rosiñol; Marjolein van der Klift; Roberto Mina; Albert Oriol; Eirini Katodritou; Ka Lung Wu; Paula Rodríguez Otero; Roman Hájek; Elisabetta Antonioli; Mark van Duin; Mattia D’Agostino; Joaquín Martínez-López; Elena M. van Leeuwen-Segarceanu; Elena Zamagni; Niels W. C. J. van de Donk; Katja C. Weisel; Luděk Pour; Jakub Radocha; Angelo Belotti; Fredrik Schjesvold; Joan Bladé; Hermann Einsele; Pieter Sonneveld; Mario Boccadoro; Annemiek Broijl
Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome

揭示超脆弱人群：非移植适应症的 newly diagnosed 多发性骨髓瘤患者中的一个独特亚组，具有较差的临床结局

HemaSphere
IF14.6
2025-12-080
OAAI
Kazimierz Groen; Febe Smits; Kazem Nasserinejad; Mark-David Levin; Josien C. Regelink; Gert-Jan Timmers; Esther G. M. de Waal; Matthijs Westerman; Gerjo A. Velders; Koen de Heer; Rineke B. L. Leys; Roel J. W. van Kampen; Claudia A. M. Stege; Maarten R. Seefat; Inger S. Nijhof; Ellen van der Spek; Saskia K. Klein; Niels W. C. J. van de Donk; Paula F. Ypma; Sonja Zweegman
Comparative Efficacy of Talquetamab vs. Real-World Physician’s Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent

三药类暴露的复发/难治性多发性骨髓瘤中塔奎他单抗与真实世界医生选择治疗的比较疗效：MonumenTAL-1与LocoMMotion/MoMMent的更新分析

Advances in Therapy
IF4
2025-11-280
OAAI
Hermann Einsele; Philippe Moreau; Nizar Bahlis; Manisha Bhutani; Laure Vincent; Lionel Karlin; Aurore Perrot; Hartmut Goldschmidt; Niels W. C. J. van de Donk; Enrique M. Ocio; Joaquín Martínez López; Paula Rodríguez-Otero; Dominik Dytfeld; Andrzej Jakubowiak; Carolina Schinke; Britta Besemer; Sébastien Anguille; Salomon Manier; Leo Rasche; Raphael Teipel; Christof Scheid; Charlotte Pawlyn; Michele Cavo; Joris Diels; Francesca Ghilotti; Bonnie W. Lau; Thomas Renaud; Oleksiy Orel; Fenny Ong; Diogo F. Ramos; Eric Ammann; Trilok Parekh; Claire Albrecht; Katja Weisel; María-Victoria Mateos
Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4

在CARTITUDE-1、-2和-4研究中，接受ciltacabtagene autoleucel输注治疗复发/难治性MM患者的颅神经麻痹临床经验。

Blood Cancer Journal
IF11.6
2025-11-260
OAAI
Paula Rodríguez-Otero; Surbhi Sidana; Mathilde Kouwenhoven; Jordan M. Schecter; Nikoletta Lendvai; Kevin C. De Braganca; Ana Slaughter; Carolina Lonardi; Philip Vlummens; Helen Varsos; Christina Corsale; Deepu Madduri; Hao Zhao; Katherine Li; Erin Lee; Loreta Marquez; Man Zhao; Tzu-min Yeh; Diana Chen; Vicki Plaks; Rocio Montes de Oca; Erika Florendo; Nitin Patel; Muhammad Akram; Mythili Koneru; Bianca D. Santomasso; Jaime Gállego Perez-Larraya; Niels WCJ van de Donk
Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network

BCMA-和GPRC5D靶向免疫疗法在多发性骨髓瘤中的序贯治疗：欧洲骨髓瘤网络实用指南

HEMASPHERE
IF14.6
2025-11-250
OAAI
van de Donk, Niels W. C. J.; Moreau, Philippe; San-Miguel, Jesus F.; Mateos, Maria-victoria; Dimopoulos, Meletios A.; Zweegman, Sonja; Gay, Francesca; Engelhardt, Monika; Mina, Roberto; Zamagni, Elena; Delforge, Michel; Beksac, Meral; Spencer, Andrew; Schjesvold, Fredrik; Driessen, Christoph; Kaiser, Martin; Perrot, Aurore; Wasch, Ralph; Korst, Charlotte L. B. M.; Broijl, Annemiek; Touzeau, Cyrille; Manier, Salomon; Hajek, Roman; Bila, Jelena; Seval, Guldane C.; O'dwyer, Michael; Ludwig, Heinz; Fernandez de Larrea, Carlos; Popat, Rakesh; Musto, Pellegrino; Rodriguez-Otero, Paula; Yong, Kwee; Kortum, Marin; Rasche, Leo; Terpos, Evangelos; Raab, Marc S.; Boccadoro, Mario; Sonneveld, Pieter; Einsele, Hermann
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma

帕博利珠单抗替代给药方案在多发性骨髓瘤治疗中的药代动力学和药效动力学评价

British Journal of Haematology
IF3.8
2025-11-030
OAAI
M. R. Seefat; D. G. J. Cucchi; L. van Boven; N. Durdu-Rayman; K. Groen; M.-D. Levin; K. de Heer; B. de Valk; R. Wester; E. van der Spek; R. Rentenaar; C. L. B. M. Korst; M. Quik; C. A. O'Neill; P. Tzortzi; F. Smits; R. Mathot; M. R. Heerma van Voss; N. W. C. J. van de Donk; T. Mutis; I. H. Bartelink; S. Zweegman
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma

欧洲骨髓瘤网络工作组关于下一代测序在 newly diagnosed multiple myeloma 预后分层中应用的共识声明

HemaSphere
IF14.6
2025-10-130
OAAI
Niccolò Bolli; Mattia D'Agostino; Tina Bagratuni; Mario Boccadoro; Michele Cavo; Christoph Driessen; Hermann Einsele; Monika Engelhardt; Francesca Gay; Norma C. Gutiérrez; Roman Hájek; Toril Holien; Cristina João; Martin Kaiser; K. Martin Kortüm; Lisa Leypoldt; Philippe Moreau; Pellegrino Musto; Enrique M. Ocio; Marc S. Raab; Leo Rasche; Fredrik Schjesvold; Tereza Sevcikova; Evangelos Terpos; Cyrille Touzeau; Niels W. C. J. Van de Donk; Mark van Duin; Katja Weisel; Elena Zamagni; Tom Cupedo; Pieter Sonneveld; Carolina Terragna
Circulating tumor cells predict myeloma outcomes in daratumumab, bortezomib, lenalidomide, dexamethasone treated patients

循环肿瘤细胞预测接受达拉妥单抗、硼替佐米、来那度胺和地塞米松治疗的多发性骨髓瘤患者的预后

Blood
IF23.1
2025-10-100
OAAI
Luca Bertamini; Cathelijne Fokkema; Paula Rodriguez-Otero; Mark van Duin; Evangelos Terpos; Mattia D’Agostino; Vincent H.J. van der Velden; Niels W.C.J. van de Donk; Michel Delforge; Christoph Driessen; Roman Hajek; Hermann Einsele; Annette Vangsted; Diego Vieyra; Ricardo Attar; Anna Sitthi-Amorn; Robin Carson; Fredrik Schjesvold; Pawel Robak; Meral Beksac; Andrew Spencer; Annemiek Broijl; Tom Cupedo; Philippe Moreau; Mario Boccadoro; Pieter Sonneveld
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform

基于EMN–HARMONY联盟平台的机器学习风险分层策略用于多发性骨髓瘤：见解

HemaSphere
IF14.6
2025-10-090
OAAI
Adrian Mosquera Orgueira; Marta Sonia Gonzalez Perez; Mattia D'Agostino; David A. Cairns; Alessandra Larocca; Juan José Lahuerta Palacios; Ruth Wester; Uta Bertsch; Anders Waage; Elena Zamagni; Carlos Pérez Míguez; Javier Alberto Rojas Martínez; Elias K. Mai; Davide Crucitti; Hans Salwender; Daniele Dall'Olio; Gastone Castellani; Manuel Piñeiro Fiel; Sara Bringhen; Sonja Zweegman; Michele Cavo; Sofía Iqbal; Jesus Maria Hernandez Rivas; Benedetto Bruno; Gordon Cook; Martin F. Kaiser; Hartmut Goldschmidt; Niels W. C. J. Van De Donk; Graham Jackson; Jesús F. San-Miguel; Mario Boccadoro; Maria-Victoria Mateos; Pieter Sonneveld
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels

老年新诊断多发性骨髓瘤患者的免疫特征与一线治疗的生存结局相关，且与脆弱性水平无关。

HemaSphere
IF14.6
2025-10-050
OAAI
Wassilis S. C. Bruins; Febe Smits; Carolien Duetz; Kazem Nasserinejad; Kazimierz Groen; Charlotte L. B. M. Korst; A. Vera de Jonge; Rosa Rentenaar; Tamara Hageman; Meliha Cosovic; Merve Eken; Inoka Twickler; Paola M. Homan-Weert; Christie P. M. Verkleij; Kristine Frerichs; Mark-David Levin; Ellen van der Spek; Inger S. Nijhof; Roel van Kampen; Niels W. C. J. van de Donk; Sonja Zweegman; Tuna Mutis
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma

来自MonumenTAL-1研究的talquetamab在复发/难治性多发性骨髓瘤患者中细胞因子释放综合征的表征与管理

Cancer Medicine
IF3.1
2025-10-020
OAAI
Niels W. C. J. van de Donk; Ajai Chari; Thomas Martin; Amrita Krishnan; Leo Rasche; Jing Christine Ye; Rakesh Popat; Brea Lipe; Cesar Rodriguez; Carolina Schinke; Sheri Skerget; Deeksha Vishwamitra; Raluca Verona; Jue Gong; Indrajeet Singh; Michela Campagna; Tara Masterson; Brandi Hilder; Jaszianne Tolbert; Thomas Renaud; M. Damiette Smit; Christoph Heuck; Maria-Victoria Mateos

研究方向

暂未获取到该数据
S
Sonja Zweegman
H 指数:87论文数:772被引数:3.2万
P
Pieter Sonneveld
H 指数:126论文数:1,252被引数:7.6万
P
Philippe Moreau
H 指数:159论文数:2,293被引数:10.7万
M
María‐Victoria Mateos
H 指数:108论文数:1,454被引数:5.7万
T
Tuna Mutis
H 指数:61论文数:344被引数:1.3万
H
Hermann Einsele
H 指数:138论文数:1,603被引数:7.3万
F
Francesca Gay
H 指数:60论文数:443被引数:1.7万
M
Mario Boccadoro
H 指数:98论文数:1,179被引数:4.7万
E
Evangelos Terpos
H 指数:106论文数:1,609被引数:5.3万
M
Michèle Cavo
H 指数:120论文数:1,472被引数:6.9万